:::

詳目顯示

回上一頁
題名:由美國立法經驗探討促進兒科試驗暨兒科用藥研究之合理措施
書刊名:高大法學論叢
作者:陳文吟 引用關係
作者(外文):Chen, Wen-yin
出版日期:2013
卷期:9:1
頁次:頁107-111 113-166
主題關鍵詞:專利權兒科臨床試驗兒科研究兒科評估資料專屬權市場專屬權罕見疾病孤兒藥法Patent rightsPediatric clinical trialsPediatric studyPediatric assessmentData exclusivityMarketing exclusivityRare diseasesOrphan drug act
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(1) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:35
期刊論文
1.蔡慧珊(2003)。無許可證及非仿單標示處方於兒童之安全性。成醫藥誌,13(1),1-3。  延伸查詢new window
2.Bain, Lisa(2005)。Crossroads in Clinical Trials。NEURO RX,2,525-528。  new window
3.Barnes, Pamela(2008)。Inside the Medicine Cabinet: Making Children's medicines Growing up Issue。Journal of Pharmaceutical Science,97,5074-5079。  new window
4.Cohen, I. Glenn(2003)。The Therapeutic Orphans, Pediatric Victims? The Best Pharmaceuticals for Children Act and Existing Pediatric Human Subject Protection。Food and Drug Law Journal,58,661-709。  new window
5.Glover, Gregory(2007)。The Influence of Market exclusivity on Drug Availability and Medical Innovations。AAPS Journal,9,E312-E316。  new window
6.Hall, Ralph、Braun, Tracy(2008)。Leaving No Child Behind? Abigail Alliance, Pediatric Products and Off-label Use。Houston Journal of Health Law and Policy.,8,271-313。  new window
7.Jerles, Lisa(2008)。Note: The Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act-Helping or Hurting America's Children?。Cardozo Public Law, Policy and Ethics Journal,6,515-545。  new window
8.Kushner, Leslie(2009)。Incentivizing Postmarketing Pharmaceutical Product Safety Testing with Extension of Exclusivity Periods。Fordham Intellectual Property, Media and Entertainment Law Journal,19,519-556。  new window
9.Li, Jennifer、Eisenstein, Eric、Grabowski, Henry、Reid, Elizabeth、Mangum, Barry、Schulman, Kevin、Goldsmith, John(2007)。Economic Return of Clinical Trials Performed Under the Pediatric Exclusivity Program。JAMA,297,480-488。  new window
10.Lynch, Holly(2007)。Give Them What They Want? The Permissibility of Pediatric Placebo-Controlled Trials the Best Pharmaceuticals for Children Act。Annals of Health Law,16,79-138。  new window
11.Milne, Christopher-Paul、Bruss, Jon(2008)。The Economics of Pediatric Formulation Development for Off-Patent Drugs。Clinical Therapeutics,30,2133-2145。  new window
12.Milne, Christopher-Paul(2002)。Exploring the Frontiers of Law and Science: FDAMA's Pediatric Studies Incentive。Food and Drug Law Journal,57,491-517。  new window
13.Noah, Barbara(2009)。Just a Spoonful of Sugar: Drug Safety for Pediatric Populations。Journal of Law, Medicine and Ethics,37,280-286。  new window
14.Shirkey, Harry(1968)。Editorial Comment: Therapeutic Orphans。Pediatrics,72,119。  new window
15.Standing, Joseph、Khaki, Zahra、Wong, Ian(2005)。Poor Formulation Information in Published Pediatric Drug Trial。Pediatrics,116,559-562。  new window
16.Tabor, Edward(2009)。FDA requirements for clinical studies in pediatric patients。Regulatory Focus,14,16-21。  new window
17.Thorat, Chandana、Xu, Kui、Freeman, Scott N.、Bonnel, Renan A.、Joseph, Francesca、Phillips, M.、Ian Imoisili, Menfo A.(2012)。What the Orphan Drug Act Has Done Lately for Children With Rare Diseases: A 10-Year Analysis。Pediatrics,129,516-521。  new window
18.Ward, R. M.、Kern, S. E.(2009)。Clinical Trials in Neonates: A Therapeutic Imperative。Clinical Pharmacology and Therapeutics,86,585-587。  new window
19.Wendler, David、Rackoff, Jonathan、Emanuel, Ezekiel、Grady, Christine(2002)。The Ethics of Paying for Children's Participation in Research。Journal of Pediatrics,141,166-171。  new window
會議論文
1.Weiss, Karen(20070531)。FDA Background Package for June 27, 2007 Meeting。  new window
研究報告
1.Thomas, John(2006)。Proprietary Rights in Pharmaceutical Innovation: Issues at the Intersection of Patents and Marketing Exclusivities。  new window
圖書
1.Clothier, Anne(2009)。Pediatric Market Dynamics。PEDIATRIC DRUG DEVELOPMENT。U.S.A.:John Wiley & Sons。  new window
2.GAO(2009)。Pediatric Drug Research: The Study and Labeling of Drugs for Pediatric Use under the Best Pharmaceuticals for Children Act。SAFETY EFFORTS IN PEDIATRIC DRUG DEVELOPMENT。U.S.A.:Nova Science Publishers。  new window
3.GAO(2009)。Pediatric Drug Research: Studies Conducted under Best Pharmaceuticals for Children Act。SAFETY EFFORTS IN PEDIATRIC DRUG DEVELOPMENT。U.S.A.:Nova Science Publishers。  new window
4.Koski, Greg(2009)。Perspectives on Pediatric Clinical Trials: The Good, the Bad, and the Ugly。PEDIATRIC DRUG DEVELOPMENT。U.S.A.:John Wiley & Sons。  new window
5.Milne, Christopher-Paul(2009)。Pharmaceutical Economics and Applications to Pediatrics: Business Case Pediatric Drug Development。PEDIATRIC DRUG DEVELOPMENT。U.S.A.:John Wiley & Sons。  new window
6.Thaul, Susan(2010)。FDA's Authority to Ensure That Drugs Prescribed to Children Are Safe and Effective。SAFETY EFFORTS IN PEDIATRIC DRUG DEVELOPMENT。U.S.A.:Nova Science Publishers。  new window
7.Wright, Elisabeth Ann、Rose, Klaus(2010)。European Union Pediatric Regulation: Theory and Practice。GUIDE TO PEDIATRIC DRUG DEVELOPMENT AND CLINICAL RESEARCH。Karger:Switzerland。  new window
8.鄭中人(2009)。專利法規釋義。臺北:考用出版股份有限公司。  延伸查詢new window
9.謝銘洋(2011)。智慧財產權法。臺北:元照出版社。  延伸查詢new window
10.楊崇森(2007)。專利法理論與運用。台北:三民書局股份有限公司。  延伸查詢new window
其他
1.內政部戶政司(2013)。民國102年3月戶口統計資料分析,http://www.moi.gov.tw/chi/chi_news/news_deail.aspx?sn=7274&type_code=01&search_k=%e6%88%b6%e5%8f%a3%e7%b5%b1%e8%a8%88%e8%b3%87%e6%96%99&pages=0, 2013/05/05。  new window
2.經濟部智慧財產局(2013)。專利審查基準彙編第二篇「發明專利實體審查」,第二章《何謂發明》暨第三章《專利要件》,http://www.IPO.gov.tw, 2013/03/10。  延伸查詢new window
3.衛生署(2007)。提升兒童醫療品質之說明,http://www.mohw.gov.tw/CHT2006/DM/DM2_p01.aspx?class_no=0&now_fod_list_no=&level_no=&doc_no=52124, 2013/04/20。  new window
4.衛生署(2013)。兒童節給全國兒童的賀禮設立兒童醫院兒童醫療新紀元,http://www.doh.gov.tw/CHT2006/DM/DM2_p01.aspx?class_no=25&level_no=1&doc_no=88082, 2013/04/20。  延伸查詢new window
5.醫療改革基金會(2006)。良藥不再難入口--小兒製劑父母心,http://www.thrf.org.tw/Page_Show.asp?Page_ID=352, 2013/04/27。  延伸查詢new window
6.醫療改革基金會(2006)。兒童吃藥冒大險正視兒童藥劑的重要性,http://www.thrf.org.tw/Page_Show.asp?Page_ID=410, 2013/04/27。  延伸查詢new window
7.醫療改革基金會(2007)。醫改會公佈:健保兒童專用藥至少102種--請家長先查詢,勇敢向醫師要求,拒絕再吃磨粉的大人藥,http://www.thrf.org.tw/Page_Show.asp?Page_ID =610, 2013/04/20。  延伸查詢new window
8.醫療改革基金會(2008)。醫改會公布最新兒童用藥調查結果樂見臺灣兒童健康人權提昇,http://www.thrf.org.tw/Page_Show.asp?Page_ID=830, 2013/04/20。  延伸查詢new window
9.醫療改革基金會(2011)。醫改會調查彙整現有兒童藥劑品項表,http://www.thrf.org.tw/child/word/05.xls, 2013/04/20。  延伸查詢new window
10.Arnum, Patricia Van(20110510)。PhRMA Urges Congress to Reauthorize Legislation for Pediatric Drugs,http://biopharminternational.findpharma.com/biopharm/News/PhRMA-Urges-Congress-to-Reauthorize-Legislation-fo/ArticleStandard/ Article/detail/721705, 2011/12/10。  new window
11.Center Watch, Understanding Informed Consent,http://pediatrics.about.com/gi/o.htm?zi=1/XJ&zTi=1&sdn=pediatrics&cdn=health&tm=30&gps=120_281_1000_522&f=00&tt=14&bt=1&bts=1&zu=http%3A//www.centerwatch.com/patient/studies/area15.html, 2011/10/16。  new window
12.Conger, Krista(2005)。What would Goldilocks do? When it comes to medicine for kids finding a dose that's just right is largely a matter of luck, Stanford Medicine Magazine,http://stanmed.stanford.edu/2005summer/kidsdrugs.html, 2011/06/13。  new window
13.Drug Research and Children,http://www.fda.gov/Drugs/ResearchForYou/Consumers/ucm143565.htm, 2011/06/20。  new window
14.Elizabeth's Story,http://www.pedaids.org/ElizabethsStory, 2011/06/13。  new window
15.FDA(20130408)。Breakdown of FDAAA Completed Pediatric Studies Between Sept. 27, 2007 and April 5, 2013,http://www.fda.gov/Drugs/DevelopmentApprovalProcess/Development Resources/ucm190622.htm, 2013/04/27。  new window
16.FDA(1998)。Information Sheets Guidance for Institutional Review Boards and Clinical Investigators,http://www.fda.gov/oc/ohrt/irbs/toc4.html, 2011/11/05。  new window
17.FDA(20080117)。Public Health Advisory: FDA Recommends that Over-the-Counter (OTC) Cough and Cold Products not be used for Infants and Children under 2 Years of Age,http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/rugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm051137.htm, 2011/06/13。  new window
18.GAO REPORT(201105)。Pediatric Research - Products Studied under Two Related Laws, But Improved (U.S.A.: GAO),http://www.gao.gov/assets/320/319073.pdf, 2013/04/27。  new window
19.Goodman, Jesse(20100721)。Rare and Neglected Pediatric Diseases, before Committee on Health, Education, Labor and Pensions, United States Senate,http://www.hhs.gov/asl/testify/2010/07/t20100721b.html, 2013/04/27。  new window
20.(20070125)。Government tested AIDS drugs on foster kids,http://www.rinf.com/news/nov05/testedAIDS.html, 2011/10/15。  new window
21.Gupta, Sanjay。Are Old Drugs Better than New?,http://www.time.com/time/magazome/article/0,9171,1002419,00.html, 2011/12/03。  new window
22.Reinberg, Steven(20080328)。New Drugs No Better Than Older Ones for Schizophrenia,http://www.washingtonpost.com/wp-dyn/content/article/2008/03/28/AR2008032801723.html, 2011/12/03。  new window
23.U.S. Census Bureau, Population by Sex and Selected Age Groups: 2000 and 2010,http://www.census.gov/prod/cen2010/briefs/c2010br-03.pdf, 2011/10/22。  new window
24.(20080414)。University of Michigan C.S. Mott Children's Hospital, National Poll on Children's Health, Is My Child's Medicine FDA-Approved?,http://health.med.umich.edu/body.cfm?id=385, 2011/12/01。  new window
25.Woodcock, Janet。Implementation of the Pediatric Exclusivity Provisions, the testimony before the Senate Committee on Health, Education, Labor, and Pensions,http://www.fda.gov/NewsEvents/Testimony/ucm115220.htm, 2011/12/10。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE